Navigation Links
Ingenuity Systems Announces Multi-Year Deal With AstraZeneca

REDWOOD CITY, Calif., May 5 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, today announced a multi-year agreement with AstraZeneca. AstraZeneca plans to expand the utilization of IPA in its research and target discovery programs to gain deeper domain knowledge of disease-related pathways and targets.

As part of the agreement, AstraZeneca researchers plan to leverage the powerful analysis application, to build biological models, analyze data, and reliably answer sophisticated biological and chemical questions in their effort to identify and progress promising targets.

Results generated in IPA can be easily shared across teams, so researchers can work together to make more informed decisions. "IPA is an extensive platform for understanding and communicating the dynamic behaviors of complex biological systems," said Dr Ian Dix, Principal Informatics Scientist, AstraZeneca. "IPA can support a wide range of research objectives across our target and biomarker discovery programs - such as providing insight into target efficacy, drugability and, increasingly, toxicity. The richness and contextual nature of the content is important for us because it provides a detailed view of the molecular basis of disease, critical in the drug discovery decision-making process."

"We are pleased to enhance and extend our relationship with AstraZeneca and to continue to provide AstraZeneca's researchers with greater workflow and decision support," said Sean Scott, SVP of Sales and Operations at Ingenuity Systems. "IPA continues to deliver value to AstraZeneca researchers by providing the right capabilities and content to understand biological systems and uncover insights that impact business decisions."

About Ingenuity Pathways Analysis

Ingenuity Pathways Analysis (IPA) is an all-in-one software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA's search capabilities provide users with access to the highest quality detail-rich knowledge available on genes, drugs, chemicals, protein families, cellular and disease processes, and signaling and metabolic pathways. IPA supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and development process, including target identification and validation, biomarker discovery, molecular toxicology, metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in hundreds of peer-reviewed journals.

About Ingenuity Systems(R)

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. Our long-term focus on innovation in semantic search has allowed us to create groundbreaking technologies that have one common goal -- to generate maximum value from all types of biological and chemical knowledge. Ingenuity offerings leverage the Ingenuity Knowledge Base, which contains uniquely structured literature findings that allow scientists to ask complex biological questions and gain rapid insight into their experimental data or systems of interest. Today, Ingenuity's solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, academic, and government research institutions worldwide. For more information visit:

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US$ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. For more information visit:

SOURCE Ingenuity Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform
2. Ingenuitys Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference
3. Ingenuity Systems Delivers Key Milestones in FDA Collaboration to Facilitate Genomic Data Review
4. Waters UPLC and HDMS Ignite Scientific Ingenuity with New System Solutions at Pittcon 2008
5. Neogen Acquires International Diagnostic Systems
6. Healthcare Management Systems Celebrates 25 Years
7. Electronic prescribing systems boost efficiency, may lead to improved quality of care
8. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
9. Dynasplint Systems, Inc. Launches Two New Web Sites Plus Social Media Tools
10. IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems
11. Sanuvox UV Air Sterilization Systems Ability to Destroy Airborne Type A Influenza including Swine Flu (H1N1)
Post Your Comments:
(Date:6/27/2016)... ... 2016 , ... "FCPX editors can now reveal their media with growing colorful ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings the ... can now reveal the media of their split screens with growing colorful panels. , ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
Breaking Medicine Technology: